Minerva Surgical Inc.

40 articles about Minerva Surgical Inc.

• Minerva Surgical Reports Third Quarter 2023 Financial Results

  11/13/2023

  Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a women's health company focused on solutions to meet the distinct uterine healthcare needs of women, today reported third quarter financial results for the period ended September 30, 2023.

• Minerva Surgical Reports Second Quarter 2023 Financial Results

  8/2/2023

  Minerva Surgical, Inc. reported second quarter financial results for the period ended June 30, 2023.

• Minerva Surgical Reports First Quarter 2023 Financial Results

  5/2/2023

  Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company) today reported first quarter financial results for the period ended March 31, 2023.

• Minerva Surgical to Announce First Quarter 2023 Financial Results

  4/18/2023

  Minerva Surgical, Inc., a medical technology company focused on solutions to meet the distinct uterine healthcare needs of women, announced that it will release its first quarter 2023 financial results on Tuesday, May 2, 2023.

• Minerva Surgical Reports Fourth Quarter and Full-Year 2022 Financial Results

  3/21/2023

  Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a woman's health company focused on solutions to meet the distinct uterine healthcare needs of women, today reported fourth quarter and full-year financial results for the period ended December 31, 2022.

• Minerva Surgical Announces the Appointment of Kaile Zagger as Chief Commercial Officer

  3/21/2023

  Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical), a women's health company focused on solutions to meet the distinct uterine healthcare needs of women, announced today the appointment of Kaile Zagger as its new Chief Commercial Officer.

• Minerva Surgical to Announce Fourth Quarter and Full Year 2022 Financial Results

  3/8/2023

  Minerva Surgical, Inc. (Nasdaq: UTRS), a woman’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that it will release its fourth quarter and full year 2022 financial results on Tuesday, March 21, 2023.

• Minerva Surgical Closes $30 Million Private Placement of Common Stock - February 09, 2023

  2/9/2023

  Minerva Surgical, Inc. announced that it has closed on the sale of 146,627,565 shares of its common stock in a private placement, led by Accelmed Partners, with participation by New Enterprise Associates, at an offering price of $0.2046 per share.

• Minerva Surgical to Present at the 41st Annual J.P. Morgan Healthcare Conference

  1/3/2023

  Minerva Surgical, Inc. announced that its management team will present at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12th at 9:45 a.m. Pacific Time.

• Minerva Surgical Announces Retirement of CEO David Clapper and Appointment of Todd Usen as Company President and CEO

  12/28/2022

  Minerva Surgical, Inc., a women's health company focused on the treatment of Abnormal Uterine Bleeding, announced that David Clapper, who has served as President and Chief Executive Officer since 2011, has chosen to retire.

• Minerva Surgical Announces $30 Million Private Placement of Common Stock Led by Accelmed Partners

  12/27/2022

  Minerva Surgical, Inc. announced that it has entered into a share purchase agreement for the sale of 146,627,565 shares of its common stock in a private placement, led by Accelmed, with participation by New Enterprise Associates, at an offering price of $0.2046 per share.

• Minerva Surgical to Present at the 34th Annual Piper Sandler Healthcare Conference

  11/21/2022

  Minerva Surgical, Inc. (Nasdaq: UTRS), a woman’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that its management will present at the 34th Annual Piper Sandler Healthcare Conference on Wednesday, November 30, 2022 at 11:00 a.m. Eastern Time in New York City, NY.

• Minerva Surgical Reports Third Quarter 2022 Financial Results

  11/14/2022

  Minerva Surgical, Inc., a woman's health company focused on the treatment of Abnormal Uterine Bleeding, reported third quarter financial results for the period ended September 30, 2022.

• Minerva Surgical Announces Change of Date for Third Quarter 2022 Earnings Release and Conference Call

  11/7/2022

  Minerva Surgical, Inc., a woman’s health company focused on the treatment of Abnormal Uterine Bleeding, announced that it has changed the date of its previously announced earnings conference call.

• Minerva Surgical to Announce Third Quarter 2022 Financial Results

  10/26/2022

  Minerva Surgical, Inc., a woman’s health company focused on the treatment of Abnormal Uterine Bleeding, announced that it will release its third quarter 2022 financial results on Wednesday, November 9, 2022.

• Minerva Surgical to Present at the H.C. Wainwright 24th Annual Global Investment Conference

  8/29/2022

  Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a woman's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that its management will present at the H.C. Wainwright 24th Annual Global Investment Conference.

• Minerva Surgical Reports Second Quarter 2022 Financial Results

  8/9/2022

  Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a woman's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), today reported second quarter financial results for the period ended June 30, 2022.

• Minerva Surgical Announces Time To Talk Campaign

  8/3/2022

  Minerva Surgical, Inc. – The Uterine Health Company, focused on the treatment of Abnormal Uterine Bleeding, announced their Time To Talk social media campaign and local event series.

• Minerva Surgical to Announce Second Quarter 2022 Financial Results

  7/28/2022

  Minerva Surgical, Inc., a woman’s health company focused on the treatment of Abnormal Uterine Bleeding, announced that it will release its second quarter 2022 financial results on Tuesday, August 9, 2022.

• Minerva Surgical Announces Appointment of Derrick Sung, Ph.D. to Board of Directors

  7/21/2022

  Minerva Surgical, Inc. (Nasdaq: UTRS) (“Minerva Surgical” or the “Company”), a woman's health company focused on the treatment of Abnormal Uterine Bleeding (AUB), today announced that the board of directors (the “Board”) of Minerva Surgical has appointed Derrick Sung, Ph.D. to serve as a Class II director, with a term expiring at the 2023 annual meeting of stockholders or until his successor has been duly elected and qualified.